Search Within

Genitourinary Oncology Service

  1. "2017"
Formats
  1. Journal Article (155)
  2. Meeting Abstract (118)
  3. Book Section (1)
Groups
  1. Department of Medicine (274)
  2. Solid Tumor Oncology Division (274)
  3. GSK Faculty (81)
  4. Department of Pathology and Laboratory Medicine (79)
  5. Human Oncology and Pathogenesis Program (77)
  6. Surgery (55)

More Groups

People
  1. David Solit (52)
  2. Robert Motzer (51)
  3. Howard Scher (44)
  4. Michael Berger (37)
  5. Dean Bajorin (35)
  6. Jonathan Rosenberg (33)

More People

Years
  1. 2017 (274)
Publications
  1. Journal of Clinical Oncology (63)
  2. Annals of Oncology (35)
  3. Clinical Cancer Research (15)
  4. European Urology (10)
  5. Laboratory Investigation (9)
  6. Modern Pathology (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (67)
  2. Oxford University Press (39)
  3. Nature Publishing Group (26)
  4. Elsevier Science, Inc. (24)
  5. American Association for Cancer Research (23)
  6. Elsevier Inc. (14)

More Publishers

Results (274)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic alterations and outcomes with VEGF-targeted therapy in patients with clear cell renal cell carcinoma
    Journal Article

    Carlo, M. I.; Manley, B.; Patil, S.; Woo, K. M.; Coskey, D. T.; Redzematovic, A.; Arcila, M.; Ladanyi, M.; Lee, W.; Chen, Y. B.; more...
    Kidney Cancer (2017)

    Fulltext@MSK | Save
  • PTEN loss-of-function alterations are associated with intrinsic resistance to BRAF inhibitors in metastatic melanoma
    Journal Article

    Catalanotti, F.; Cheng, D. T.; Shoushtari, A. N.; Johnson, D. B.; Panageas, K. S.; Momtaz, P.; Higham, C.; Won, H. H.; Harding, J. J.; Merghoub, T.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • The hematopoietic cell transplantation comorbidity index (HCT-CI) is not predictive of outcomes in germ CE cancer patients receiving autologous transplantation
    Meeting Abstract

    Greenberg, D.; Shah, G. L.; Maloy, M.; Devlin, S. M.; Giralt, S. A.; Perales, M. A.; Feldman, D. R.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making
    Journal Article

    Abida, W.; Armenia, J.; Gopalan, A.; Brennan, R.; Walsh, M.; Barron, D.; Danila, D.; Rathkopf, D.; Morris, M.; Slovin, S.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • OncoKB: A precision oncology knowledge base
    Journal Article

    Chakravarty, D.; Gao, J.; Phillips, S.; Kundra, R.; Zhang, H.; Wang, J.; Rudolph, J. E.; Yaeger, R.; Soumerai, T.; Nissan, M. H.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • Efficacy, safety, and immune activation with pegylated human IL-10 (AM0010) in combination with an anti-PD1 in advanced NSCLC
    Meeting Abstract

    Wong, D. J. L.; Schneider, J. G.; Aljumaily, R.; Korn, W. M.; Infante, J. R.; Patel, M. R.; Autio, K. A.; Papadopoulos, K. P.; Naing, A.; Gabrail, N. Y.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • The immunomodulatory protein Dickkopf-1 (DKK1) defines a non-neuroendocrine subtype of metastatic castration-resistant prostate cancer (mCRPC) with low AR and low PSA expression
    Meeting Abstract

    Wise, D.; Armenia, J.; Chen, Y.; Nelson, P.; Schultz, N.; Sawyers, C. L.; Scher, H. I.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Integrated biomarker analysis for 412 renal cell cancer (RCC) patients (pts) treated on the phase 3 COMPARZ trial: Correlating common mutation events in PBRM1 and BAP1 with angiogenesis expression signatures and outcomes on tyrosine kinase inhibitor (TKI) therapy
    Meeting Abstract

    Voss, M. H.; Kuo, F.; Chen, D.; Marker, M.; Patel, P.; Redzematovic, A.; Riaz, N.; Chan, T. A.; Choueiri, T. K.; Hsieh, J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Clinical outcomes by nephrectomy status in METEOR, a randomized phase 3 trial of cabozantinib (cabo) vs everolimus (eve) in patients (pts) with advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Tannir, N. M.; Powles, T.; Escudier, B. J.; Donskov, F.; Grünwald, V.; Sternberg, C. N.; Schmidinger, M.; Schoffski, P.; Szczylik, C.; Peltola, K. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Pazopanib exposure response assessment as adjuvant therapy for patients with localized or locally advanced renal cell carcinoma (RCC) following nephrectomy
    Meeting Abstract

    Sternberg, C. N.; Donskov, F.; Haas, N. B.; Doehn, C.; Russo, P.; Elmeliegy, M.; Banerjee, H.; Aimone, P.; Voi, M.; Motzer, R. J.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save